CARCINOMA, HEPATOCELLULAR
Clinical trials for CARCINOMA, HEPATOCELLULAR explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, HEPATOCELLULAR trials appear
Sign up with your email to follow new studies for CARCINOMA, HEPATOCELLULAR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New chemo combo aims to control liver cancer without surgery
Disease control TerminatedThis study tested a treatment for liver cancer (hepatocellular carcinoma) in people with mild-to-moderate cirrhosis. The treatment involved injecting a chemotherapy drug (idarubicin) mixed with a fatty substance (lipiodol) directly into the liver artery. The main goal was to see …
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: PHASE2 • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Liver cancer trial halted: drug combo vs. standard therapy
Disease control TerminatedThis study aimed to see if a combination of two drugs (regorafenib and pembrolizumab) worked better than standard treatments (TACE or TARE) for people with intermediate-stage liver cancer. The trial was planned for about 496 participants but was stopped early, so only limited dat…
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: PHASE3 • Sponsor: Translational Research in Oncology • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Doctors test custom radiation doses for inoperable liver cancer
Disease control TerminatedThis study tested a personalized radiation treatment for patients with liver cancer that cannot be removed by surgery. Doctors used tiny radioactive spheres injected into the liver, with doses customized for each patient based on a preliminary test dose. The goal was to check if …
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: NA • Sponsor: Imperial College London • Aim: Disease control
Last updated Apr 16, 2026 13:01 UTC
-
Radiation therapy study seeks immune clues for better cancer treatment
Knowledge-focused TerminatedThis study looked at how the immune system responds during high-dose radiation therapy in people with liver, colorectal, melanoma, or kidney cancers. Researchers collected blood samples before, during, and after treatment to track immune cells and other markers. The goal was to l…
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: NA • Sponsor: Centre Oscar Lambret • Aim: Knowledge-focused
Last updated May 17, 2026 01:00 UTC